Collegium Pharmaceutical (COLL) Interest Coverage Ratio (2014 - 2026)
Collegium Pharmaceutical's (COLL) quarterly Interest Coverage Ratio came in at 0.34 in Q1 2026, up 42.46% year-on-year from 0.24 in Q1 2025, and down 89.23% quarter-over-quarter from 3.15 in Q4 2025.
Collegium Pharmaceutical (COLL) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 0.34 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 42.46% year-over-year to 0.34 in Q1 2026; TTM through Mar 2026 was 2.07, a 32.89% increase from a year earlier, with the FY2025 full-year figure at 1.62, down 29.44% from the prior year.
- Interest Coverage Ratio slipped to 0.34 in Q1 2026 per COLL's latest filing, from 3.15 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 3.2 in Q4 2023 and bottomed at 0.12 in Q1 2022.
- The 5-year median for Interest Coverage Ratio is 0.68 (2025), against an average of 1.28.
- Across the five-year window, Interest Coverage Ratio slumped 103.19% in 2022 and jumped 1118.05% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.57 in 2022, then jumped by 459.91% to 3.2 in 2023, then tumbled by 47.42% to 1.68 in 2024, then soared by 87.2% to 3.15 in 2025, then tumbled by 89.23% to 0.34 in 2026.
- Per Business Quant, the three latest COLL Interest Coverage Ratio figures stand at 0.34 (Q1 2026), 3.15 (Q4 2025), and 0.68 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn | 0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.34 |
| Dec 31, 2025 | 3.15 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 1.68 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 3.05 |
| Mar 31, 2024 | 2.83 |
| Dec 31, 2023 | 3.20 |
| Sep 30, 2023 | 2.17 |
| Jun 30, 2023 | 1.63 |
| Mar 31, 2023 | 1.15 |
| Dec 31, 2022 | 0.57 |
| Sep 30, 2022 | 0.25 |
| Jun 30, 2022 | 0.13 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | -7.17 |
| Sep 30, 2021 | 1.68 |
| Jun 30, 2021 | 0.91 |